Recombinant granulocyte - colony stimulating factor ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
39	Toxic epidermal necrolysis	1

39. Toxic epidermal necrolysis

Clinical trials : 13 / Drugs : 19 - (DrugBank : 8) / Drug target genes : 11 - Drug target pathways : 103

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02739295 (ClinicalTrials.gov)	July 2016	4/4/2016	G-CSF in the Treatment of Toxic Epidermal Necrolysis	Evaluation of G-CSF as a Treatment of Toxic Epidermal Necrolysis	Stevens - Johnson Syndrome	Drug: recombinant granulocyte - colony stimulating factor;Drug: NaCl 0.9%	University of Liege	NULL	Recruiting	18 Years	N/A	All	10	Phase 4	Belgium

First Previous1Next Last